A significant discovery in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently disabled in several types of tumors, causing https://wearethelist.com/story24163026/mini-antibodies-revive-p53-a-new-approach-for-tumor-treatment